Market Cap 2 Billion
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL and CINVANTI. Its pipeline product is HTX-011.
EPS -0.63 P/E Ratio 0.00
Previous Thu, May 9, 2019
Latest Mon, Aug 5, 2019 (76 days ago) Price +0.00%
Pay Date --
Aug 7, 2019
Nov 2, 2018
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.